Cite
MLA Citation
Emilie Clay et al.. “Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK.” Journal of market access & health policy, vol. 6, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100086630034.0x00000f